JP2002542253A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542253A5
JP2002542253A5 JP2000612312A JP2000612312A JP2002542253A5 JP 2002542253 A5 JP2002542253 A5 JP 2002542253A5 JP 2000612312 A JP2000612312 A JP 2000612312A JP 2000612312 A JP2000612312 A JP 2000612312A JP 2002542253 A5 JP2002542253 A5 JP 2002542253A5
Authority
JP
Japan
Prior art keywords
carbon atoms
group
alkyl
hydrogen atom
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000612312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542253A (ja
Filing date
Publication date
Priority claimed from FR9904866A external-priority patent/FR2792320B1/fr
Application filed filed Critical
Publication of JP2002542253A publication Critical patent/JP2002542253A/ja
Publication of JP2002542253A5 publication Critical patent/JP2002542253A5/ja
Pending legal-status Critical Current

Links

JP2000612312A 1999-04-19 2000-04-18 新規のリボース置換芳香族アミド、それらの製造方法及びそれらの薬剤としての使用 Pending JP2002542253A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/04866 1999-04-19
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
PCT/FR2000/000999 WO2000063222A2 (fr) 1999-04-19 2000-04-18 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
JP2002542253A JP2002542253A (ja) 2002-12-10
JP2002542253A5 true JP2002542253A5 (enExample) 2007-01-11

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000612312A Pending JP2002542253A (ja) 1999-04-19 2000-04-18 新規のリボース置換芳香族アミド、それらの製造方法及びそれらの薬剤としての使用

Country Status (24)

Country Link
US (1) US6579902B1 (enExample)
EP (1) EP1173455A2 (enExample)
JP (1) JP2002542253A (enExample)
KR (1) KR100693258B1 (enExample)
CN (1) CN1213055C (enExample)
AP (1) AP2001002312A0 (enExample)
AU (1) AU769514B2 (enExample)
CA (1) CA2363945A1 (enExample)
CZ (1) CZ20013708A3 (enExample)
EA (1) EA004304B1 (enExample)
FR (1) FR2792320B1 (enExample)
HK (1) HK1046690B (enExample)
HU (1) HUP0200778A3 (enExample)
ID (1) ID30562A (enExample)
IL (1) IL146018A0 (enExample)
NO (1) NO320703B1 (enExample)
NZ (1) NZ515108A (enExample)
PL (1) PL354192A1 (enExample)
SK (1) SK14842001A3 (enExample)
TR (1) TR200103009T2 (enExample)
UA (1) UA72919C2 (enExample)
WO (1) WO2000063222A2 (enExample)
YU (1) YU80301A (enExample)
ZA (1) ZA200108627B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
WO2006050501A2 (en) * 2004-11-03 2006-05-11 University Of Kansas Novobiocin analogues as anticancer agents
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
WO2011041593A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
CN112513058B (zh) 2018-05-14 2024-08-20 里亚塔医药公司 治疗与热休克蛋白通路有关的疾病的具有修饰糖基团的联芳基酰胺类

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Similar Documents

Publication Publication Date Title
JP2002542253A5 (enExample)
JO2644B1 (en) Derivatives of N- (amino-aryl mixture) -H1- indole-2-carboxamide Synthesis and therapeutic use
JP2005289914A5 (enExample)
MY142807A (en) Benzimidazole derivative and use thereof.
JP2006520397A5 (enExample)
JP2008503484A5 (enExample)
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
JP2006522035A5 (enExample)
MY150289A (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
NO20031232L (no) Pyridazinoner og triazinoner og medisinsk anvendelse derav
JP2004190075A5 (enExample)
EP1961734A4 (en) AMINE CONNECTION AND ITS USE FOR MEDICAL PURPOSES
JP2004535380A5 (enExample)
JP2000264961A5 (enExample)
JP2010518860A5 (enExample)
JP2007517826A5 (enExample)
YU80301A (sh) Novi aromatični amidi supstituisani ribozom, postupak za njihovo pripremanje i njihova primena kao medikamenata
TW200801023A (en) Substituded phenylethynyl gold-nitrogen containing heterocyclic carbene complex
JP2002338957A5 (enExample)
JP2004331662A5 (enExample)
JP2009525987A5 (enExample)
HUP0400854A2 (hu) Tri- és tetraaza-acenaftilén-származékok mint CRF receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
HUP0303020A2 (hu) Androgén 7-szubsztituált 11-halogénezett szteroidok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
JP2009542861A5 (enExample)
JP2002527369A5 (enExample)